- Home
- Publications
- Publication Search
- Publication Details
Title
Current and Future Treatment Strategies for Rhabdomyosarcoma
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2019-12-20
DOI
10.3389/fonc.2019.01458
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- CAR T cells targeting B7-H3, a Pan-Cancer Antigen, Demonstrate Potent Preclinical Activity Against Pediatric Solid Tumors and Brain Tumors
- (2019) Robbie G. Majzner et al. CLINICAL CANCER RESEARCH
- Visualizing Engrafted Human Cancer and Therapy Responses in Immunodeficient Zebrafish
- (2019) Chuan Yan et al. CELL
- Long-term health status of high-risk neuroblastoma survivors treated with high-dose chemotherapy and hematopoietic stem cell transplantation.
- (2019) Sandrine Haghiri et al. JOURNAL OF CLINICAL ONCOLOGY
- Insights into pediatric rhabdomyosarcoma research: Challenges and goals
- (2019) Marielle E. Yohe et al. PEDIATRIC BLOOD & CANCER
- Congenital spindle cell rhabdomyosarcoma
- (2019) Sarah B. Whittle et al. PEDIATRIC BLOOD & CANCER
- Chemical genomics reveals histone deacetylases are required for core regulatory transcription
- (2019) Berkley E. Gryder et al. Nature Communications
- Maintenance chemotherapy in rhabdomyosarcoma: the new standard of care
- (2019) William H Meyer LANCET ONCOLOGY
- Vinorelbine and continuous low-dose cyclophosphamide as maintenance chemotherapy in patients with high-risk rhabdomyosarcoma (RMS 2005): a multicentre, open-label, randomised, phase 3 trial
- (2019) Gianni Bisogno et al. LANCET ONCOLOGY
- Refinement of risk stratification for childhood rhabdomyosarcoma using FOXO1 fusion status in addition to established clinical outcome predictors: A report from the Children's Oncology Group
- (2019) Emily Hibbitts et al. Cancer Medicine
- Haploidentical allogeneic hematopoietic stem cell transplantation in patients with high-risk soft tissue sarcomas: results of a single-center prospective trial
- (2018) Michael Merker et al. BONE MARROW TRANSPLANTATION
- Fusion status in patients with lymph node-positive (N1) alveolar rhabdomyosarcoma is a powerful predictor of prognosis: Experience of the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG)
- (2018) Soledad Gallego et al. CANCER
- Maintenance low-dose chemotherapy in patients with high-risk (HR) rhabdomyosarcoma (RMS): A report from the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG).
- (2018) Gianni Bisogno et al. JOURNAL OF CLINICAL ONCOLOGY
- Addition of dose-intensified doxorubicin to standard chemotherapy for rhabdomyosarcoma (EpSSG RMS 2005): a multicentre, open-label, randomised controlled, phase 3 trial
- (2018) Gianni Bisogno et al. LANCET ONCOLOGY
- Enhancer invasion shapes MYCN-dependent transcriptional amplification in neuroblastoma
- (2018) Rhamy Zeid et al. NATURE GENETICS
- BCL-2 selective inhibitor ABT-199 primes rhabdomyosarcoma cells to histone deacetylase inhibitor-induced apoptosis
- (2018) Ulrike Heinicke et al. ONCOGENE
- Cancer immunotherapy using checkpoint blockade
- (2018) Antoni Ribas et al. SCIENCE
- MEK inhibition induces MYOG and remodels super-enhancers in RAS-driven rhabdomyosarcoma
- (2018) Marielle E. Yohe et al. Science Translational Medicine
- Pediatric Cancer Immunotherapy: Opportunities and Challenges
- (2018) Mary Frances Wedekind et al. PEDIATRIC DRUGS
- Current Treatment of Pediatric Bladder and Prostate Rhabdomyosarcoma
- (2018) Amanda F. Saltzman et al. Current Urology Reports
- Systematic identification of cancer-specific MHC-binding peptides with RAVEN
- (2018) Michaela C. Baldauf et al. OncoImmunology
- Identification of Therapeutic Targets in Rhabdomyosarcoma through Integrated Genomic, Epigenomic, and Proteomic Analyses
- (2018) Elizabeth Stewart et al. CANCER CELL
- Enhancement of Soft Tissue Sarcoma Cell Radiosensitivity by Poly(ADP-ribose) Polymerase-1 Inhibitors
- (2018) Monica Mangoni et al. RADIATION RESEARCH
- Different Response of Ptch Mutant and Ptch Wildtype Rhabdomyosarcoma Toward SMO and PI3K Inhibitors
- (2018) Natalie Geyer et al. Frontiers in Oncology
- PARP inhibitors affect growth, survival and radiation susceptibility of human alveolar and embryonal rhabdomyosarcoma cell lines
- (2018) Simona Camero et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- A Novel Notch–YAP Circuit Drives Stemness and Tumorigenesis in Embryonal Rhabdomyosarcoma
- (2017) Katherine K. Slemmons et al. MOLECULAR CANCER RESEARCH
- Tumour heterogeneity and resistance to cancer therapies
- (2017) Ibiayi Dagogo-Jack et al. Nature Reviews Clinical Oncology
- Local therapy to distant metastatic sites in stage IV rhabdomyosarcoma
- (2017) Arvind C. Mohan et al. PEDIATRIC BLOOD & CANCER
- PARP inhibitors: Synthetic lethality in the clinic
- (2017) Christopher J. Lord et al. SCIENCE
- PAX3–FOXO1 Establishes Myogenic Super Enhancers and Confers BET Bromodomain Vulnerability
- (2017) Berkley E. Gryder et al. Cancer Discovery
- Irreversible growth plate fusions in children with medulloblastoma treated with a targeted hedgehog pathway inhibitor
- (2017) Giles W. Robinson et al. Oncotarget
- The NOTCH1/SNAIL1/MEF2C Pathway Regulates Growth and Self-Renewal in Embryonal Rhabdomyosarcoma
- (2017) Myron S. Ignatius et al. Cell Reports
- Identification of clinically achievable combination therapies in childhood rhabdomyosarcoma
- (2016) Elliot Kahen et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Hedgehog Signal Transduction: Key Players, Oncogenic Drivers, and Cancer Therapy
- (2016) Ekaterina Pak et al. DEVELOPMENTAL CELL
- Helicase CHD4 is an epigenetic coregulator of PAX3-FOXO1 in alveolar rhabdomyosarcoma
- (2016) Maria Böhm et al. JOURNAL OF CLINICAL INVESTIGATION
- Intensive Multiagent Therapy, Including Dose-Compressed Cycles of Ifosfamide/Etoposide and Vincristine/Doxorubicin/Cyclophosphamide, Irinotecan, and Radiation, in Patients With High-Risk Rhabdomyosarcoma: A Report From the Children's Oncology Group
- (2016) Brenda J. Weigel et al. JOURNAL OF CLINICAL ONCOLOGY
- Metastatic Rhabdomyosarcoma: Still Room for Improvement
- (2016) Leonard H. Wexler JOURNAL OF CLINICAL ONCOLOGY
- RGD liposome-protamine-siRNA (LPR) nanoparticles targeting PAX3-FOXO1 for alveolar rhabdomyosarcoma therapy
- (2016) Venkatesh Rengaswamy et al. JOURNAL OF CONTROLLED RELEASE
- P/CAF mediates PAX3-FOXO1-dependent oncogenesis in alveolar rhabdomyosarcoma
- (2016) Narendra Bharathy et al. JOURNAL OF PATHOLOGY
- Tumor cells can follow distinct evolutionary paths to become resistant to epidermal growth factor receptor inhibition
- (2016) Aaron N Hata et al. NATURE MEDICINE
- Treating cancer with selective CDK4/6 inhibitors
- (2016) Ben O'Leary et al. Nature Reviews Clinical Oncology
- Impact of fusion gene status versus histology on risk-stratification for rhabdomyosarcoma: Retrospective analyses of patients on UK trials
- (2016) Joanna Selfe et al. PEDIATRIC BLOOD & CANCER
- Histology, Fusion Status, and Outcome in Alveolar Rhabdomyosarcoma With Low-Risk Clinical Features: A Report From the Children's Oncology Group
- (2016) Michael A. Arnold et al. PEDIATRIC BLOOD & CANCER
- Access to clinical trials for adolescents with soft tissue sarcomas: Enrollment in European pediatric Soft tissue sarcoma Study Group (EpSSG) protocols
- (2016) Andrea Ferrari et al. PEDIATRIC BLOOD & CANCER
- Rhabdomyosarcoma
- (2016) Roshni Dasgupta et al. Seminars in Pediatric Surgery
- Targeting WEE1 Kinase in Cancer
- (2016) Christopher J. Matheson et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Oncolytic virus synergizes with Smac mimetic compounds to induce rhabdomyosarcoma cell death in a syngeneic murine model
- (2016) Christine C. Dobson et al. Oncotarget
- Modular PROTAC Design for the Degradation of Oncogenic BCR-ABL
- (2015) Ashton C. Lai et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Genome-wide CRISPR Screen in a Mouse Model of Tumor Growth and Metastasis
- (2015) Sidi Chen et al. CELL
- Phase I Clinical Trial of Ipilimumab in Pediatric Patients with Advanced Solid Tumors
- (2015) M. S. Merchant et al. CLINICAL CANCER RESEARCH
- CDK4 Amplification Reduces Sensitivity to CDK4/6 Inhibition in Fusion-Positive Rhabdomyosarcoma
- (2015) M. E. Olanich et al. CLINICAL CANCER RESEARCH
- Promises and Challenges of Smac Mimetics as Cancer Therapeutics
- (2015) S. Fulda CLINICAL CANCER RESEARCH
- Does aggressive local treatment have an impact on survival in children with metastatic rhabdomyosarcoma?
- (2015) M. Ben Arush et al. EUROPEAN JOURNAL OF CANCER
- Immune Checkpoint Blockade in Cancer Therapy
- (2015) Michael A. Postow et al. JOURNAL OF CLINICAL ONCOLOGY
- Vismodegib in patients with advanced basal cell carcinoma (STEVIE): a pre-planned interim analysis of an international, open-label trial
- (2015) Nicole Basset-Seguin et al. LANCET ONCOLOGY
- Histone Deacetylase Inhibitors Inhibit Rhabdomyosarcoma by Reactive Oxygen Species-Dependent Targeting of Specificity Protein Transcription Factors
- (2015) E. Hedrick et al. MOLECULAR CANCER THERAPEUTICS
- Tumour exosome integrins determine organotropic metastasis
- (2015) Ayuko Hoshino et al. NATURE
- Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex
- (2015) Silvana Konermann et al. NATURE
- Catalytic in vivo protein knockdown by small-molecule PROTACs
- (2015) Daniel P Bondeson et al. Nature Chemical Biology
- Nivolumab and Ipilimumab versus Ipilimumab in Untreated Melanoma
- (2015) Michael A. Postow et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer
- (2015) Julie Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pembrolizumab versus Ipilimumab in Advanced Melanoma
- (2015) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Targeting hedgehog signaling reduces self-renewal in embryonal rhabdomyosarcoma
- (2015) S Satheesha et al. ONCOGENE
- Phase 2 trial of sorafenib in children and young adults with refractory solid tumors: A report from the Children's Oncology Group
- (2015) AeRang Kim et al. PEDIATRIC BLOOD & CANCER
- Phthalimide conjugation as a strategy for in vivo target protein degradation
- (2015) G. E. Winter et al. SCIENCE
- Clonality and Evolutionary History of Rhabdomyosarcoma
- (2015) Li Chen et al. PLoS Genetics
- Inhibiting phosphorylation of the oncogenic PAX3-FOXO1 reduces alveolar rhabdomyosarcoma phenotypes identifying novel therapy options
- (2015) J M Loupe et al. Oncogenesis
- IGF-1R Inhibition Activates a YES/SFK Bypass Resistance Pathway: Rational Basis for Co-Targeting IGF-1R and Yes/SFK Kinase in Rhabdomyosarcoma
- (2015) Xiaolin Wan et al. NEOPLASIA
- Hedgehog Inhibitors in Rhabdomyosarcoma: A Comparison of Four Compounds and Responsiveness of Four Cell Lines
- (2015) Rosalie Ridzewski et al. Frontiers in Oncology
- A phase 2 trial of R1507, a monoclonal antibody to the insulin-like growth factor-1 receptor (IGF-1R), in patients with recurrent or refractory rhabdomyosarcoma, osteosarcoma, synovial sarcoma, and other soft tissue sarcomas: Results of a Sarcoma Alliance
- (2014) Alberto S. Pappo et al. CANCER
- PLK1 Phosphorylates PAX3-FOXO1, the Inhibition of Which Triggers Regression of Alveolar Rhabdomyosarcoma
- (2014) V. Thalhammer et al. CANCER RESEARCH
- Toward a Drug Development Path That Targets Metastatic Progression in Osteosarcoma
- (2014) C. Khanna et al. CLINICAL CANCER RESEARCH
- Lineage of origin in rhabdomyosarcoma informs pharmacological response
- (2014) J. Abraham et al. GENES & DEVELOPMENT
- FGFR4 signaling couples to Bim and not Bmf to discriminate subsets of alveolar rhabdomyosarcoma cells
- (2014) Marco Wachtel et al. INTERNATIONAL JOURNAL OF CANCER
- Shorter-Duration Therapy Using Vincristine, Dactinomycin, and Lower-Dose Cyclophosphamide With or Without Radiotherapy for Patients With Newly Diagnosed Low-Risk Rhabdomyosarcoma: A Report From the Soft Tissue Sarcoma Committee of the Children's Oncology Group
- (2014) David O. Walterhouse et al. JOURNAL OF CLINICAL ONCOLOGY
- PhosphoSitePlus, 2014: mutations, PTMs and recalibrations
- (2014) Peter V. Hornbeck et al. NUCLEIC ACIDS RESEARCH
- A dosimetric comparison of proton and intensity modulated radiation therapy in pediatric rhabdomyosarcoma patients enrolled on a prospective phase II proton study
- (2014) Matthew M. Ladra et al. RADIOTHERAPY AND ONCOLOGY
- Comprehensive Genomic Analysis of Rhabdomyosarcoma Reveals a Landscape of Alterations Affecting a Common Genetic Axis in Fusion-Positive and Fusion-Negative Tumors
- (2014) J. F. Shern et al. Cancer Discovery
- Cell-Cycle Dependent Expression of a Translocation-Mediated Fusion Oncogene Mediates Checkpoint Adaptation in Rhabdomyosarcoma
- (2014) Ken Kikuchi et al. PLoS Genetics
- Dense Pattern of Embryonal Rhabdomyosarcoma, a Lesion Easily Confused With Alveolar Rhabdomyosarcoma
- (2013) Erin R. Rudzinski et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Targeting Oxidative Stress in Embryonal Rhabdomyosarcoma
- (2013) Xiang Chen et al. CANCER CELL
- Selective Inhibition of Tumor Oncogenes by Disruption of Super-Enhancers
- (2013) Jakob Lovén et al. CELL
- Simultaneous targeting of insulin-like growth factor-1 receptor and anaplastic lymphoma kinase in embryonal and alveolar rhabdomyosarcoma: A rational choice
- (2013) J. Carlijn van Gaal et al. EUROPEAN JOURNAL OF CANCER
- A call to ARMS: targeting thePAX3-FOXO1gene in alveolar rhabdomyosarcoma
- (2013) Mary E Olanich et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Pan-Mammalian Target of Rapamycin (mTOR) Inhibitor AZD8055 Primes Rhabdomyosarcoma Cells for ABT-737-induced Apoptosis by Down-regulating Mcl-1 Protein
- (2013) Ellen Preuss et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The mechanisms of Hedgehog signalling and its roles in development and disease
- (2013) James Briscoe et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Nivolumab plus Ipilimumab in Advanced Melanoma
- (2013) Jedd D. Wolchok et al. NEW ENGLAND JOURNAL OF MEDICINE
- PAX-FOXO1fusion status drives unfavorable outcome for children with rhabdomyosarcoma: A children's oncology group report
- (2013) Stephen X. Skapek et al. PEDIATRIC BLOOD & CANCER
- Survival following disease recurrence of primary localized alveolar rhabdomyosarcoma
- (2013) Tobias M. Dantonello et al. PEDIATRIC BLOOD & CANCER
- Cyclin-Dependent Kinase 4 Phosphorylates and Positively Regulates PAX3-FOXO1 in Human Alveolar Rhabdomyosarcoma Cells
- (2013) Lingling Liu et al. PLoS One
- Targeting Wild-Type and Mutationally Activated FGFR4 in Rhabdomyosarcoma with the Inhibitor Ponatinib (AP24534)
- (2013) Samuel Q. Li et al. PLoS One
- Radiation therapy target volume reduction in pediatric rhabdomyosarcoma
- (2012) Bree R. Eaton et al. CANCER
- The Inconvenience of Convenience Cohorts: Rhabdomyosarcoma and the PAX-FOXO1 Biomarker
- (2012) A. R. Rosenberg et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Inconvenience of Convenience Cohorts--Letter
- (2012) D. Williamson et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Relative Mitochondrial Priming of Myeloblasts and Normal HSCs Determines Chemotherapeutic Success in AML
- (2012) Thanh-Trang Vo et al. CELL
- Development of an Fc-Enhanced Anti-B7-H3 Monoclonal Antibody with Potent Antitumor Activity
- (2012) D. Loo et al. CLINICAL CANCER RESEARCH
- Radiotherapy for Rhabdomyosarcoma: Indications and Outcome
- (2012) S.A. Terezakis et al. CLINICAL ONCOLOGY
- Genomic and clinical analysis of fusion gene amplification in rhabdomyosarcoma: A report from the Children's Oncology Group
- (2012) Fenghai Duan et al. GENES CHROMOSOMES & CANCER
- Randomized Comparison of Intensified Six-Drug Versus Standard Three-Drug Chemotherapy for High-Risk Nonmetastatic Rhabdomyosarcoma and Other Chemotherapy-Sensitive Childhood Soft Tissue Sarcomas: Long-Term Results From the International Society of Pediatric Oncology MMT95 Study
- (2012) Odile Oberlin et al. JOURNAL OF CLINICAL ONCOLOGY
- PAX3/FOXO1Fusion Gene Status Is the Key Prognostic Molecular Marker in Rhabdomyosarcoma and Significantly Improves Current Risk Stratification
- (2012) Edoardo Missiaglia et al. JOURNAL OF CLINICAL ONCOLOGY
- Rhabdomyosarcoma: Review of the Children's Oncology Group (COG) soft-tissue Sarcoma committee experience and rationale for current COG studies
- (2012) Suman Malempati et al. PEDIATRIC BLOOD & CANCER
- Children's Oncology Group's 2013 blueprint for research: Soft tissue sarcomas
- (2012) Douglas S. Hawkins et al. PEDIATRIC BLOOD & CANCER
- Alveolar rhabdomyosarcoma – The molecular drivers of PAX3/7-FOXO1-induced tumorigenesis
- (2012) Amy D Marshall et al. Skeletal Muscle
- Identification of Cell Surface Proteins as Potential Immunotherapy Targets in 12 Pediatric Cancers
- (2012) Rimas J. Orentas et al. Frontiers in Oncology
- Inhibition of Notch3 signalling induces rhabdomyosarcoma cell differentiation promoting p38 phosphorylation and p21Cip1 expression and hampers tumour cell growth in vitro and in vivo
- (2011) L Raimondi et al. CELL DEATH AND DIFFERENTIATION
- Identification of serines 201 and 209 as sites of Pax3 phosphorylation and the altered phosphorylation status of Pax3-FOXO1 during early myogenic differentiation
- (2011) Kevin N. Dietz et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- R1507, a Monoclonal Antibody to the Insulin-Like Growth Factor 1 Receptor, in Patients With Recurrent or Refractory Ewing Sarcoma Family of Tumors: Results of a Phase II Sarcoma Alliance for Research Through Collaboration Study
- (2011) Alberto S. Pappo et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic Factors After Relapse in Nonmetastatic Rhabdomyosarcoma: A Nomogram to Better Define Patients Who Can Be Salvaged With Further Therapy
- (2011) Julia C. Chisholm et al. JOURNAL OF CLINICAL ONCOLOGY
- Hedgehog signal inhibitor forskolin suppresses cell proliferation and tumor growth of human rhabdomyosarcoma xenograft
- (2011) Hiroaki Yamanaka et al. JOURNAL OF PEDIATRIC SURGERY
- Prognostic value of PAX-FKHR fusion status in alveolar rhabdomyosarcoma: A report from the cooperative soft tissue sarcoma study group (CWS)
- (2011) Sabine Stegmaier et al. PEDIATRIC BLOOD & CANCER
- Hedgehog pathway activity in pediatric embryonal rhabdomyosarcoma and undifferentiated sarcoma: A report from the Children's Oncology Group
- (2011) Joseph G. Pressey et al. PEDIATRIC BLOOD & CANCER
- Pretreatment Mitochondrial Priming Correlates with Clinical Response to Cytotoxic Chemotherapy
- (2011) T. N. Chonghaile et al. SCIENCE
- Optimization of Dosing for EGFR-Mutant Non-Small Cell Lung Cancer with Evolutionary Cancer Modeling
- (2011) J. Chmielecki et al. Science Translational Medicine
- Betulinic acid induces apoptosis and inhibits hedgehog signalling in rhabdomyosarcoma
- (2010) M Eichenmüller et al. BRITISH JOURNAL OF CANCER
- The biology and treatment of EML4-ALK non-small cell lung cancer
- (2010) Takaaki Sasaki et al. EUROPEAN JOURNAL OF CANCER
- Sensitivity to Poly(ADP-ribose) Polymerase (PARP) Inhibition Identifies Ubiquitin-specific Peptidase 11 (USP11) as a Regulator of DNA Double-strand Break Repair
- (2010) Timothy D. Wiltshire et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Randomized Phase II Window Trial of Two Schedules of Irinotecan With Vincristine in Patients With First Relapse or Progression of Rhabdomyosarcoma: A Report From the Children's Oncology Group
- (2010) Leo Mascarenhas et al. JOURNAL OF CLINICAL ONCOLOGY
- Gene Expression Profiling for Survival Prediction in Pediatric Rhabdomyosarcomas: A Report From the Children's Oncology Group
- (2010) Elai Davicioni et al. JOURNAL OF CLINICAL ONCOLOGY
- Fusion Gene–Negative Alveolar Rhabdomyosarcoma Is Clinically and Molecularly Indistinguishable From Embryonal Rhabdomyosarcoma
- (2010) Daniel Williamson et al. JOURNAL OF CLINICAL ONCOLOGY
- Activation of the hedgehog pathway confers a poor prognosis in embryonal and fusion gene-negative alveolar rhabdomyosarcoma
- (2010) A Zibat et al. ONCOGENE
- Molecular Classification of Rhabdomyosarcoma—Genotypic and Phenotypic Determinants of Diagnosis
- (2009) Elai Davicioni et al. AMERICAN JOURNAL OF PATHOLOGY
- Glycogen synthase kinase 3 regulates PAX3–FKHR-mediated cell proliferation in human alveolar rhabdomyosarcoma cells
- (2009) Fu-Yue Zeng et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Trends in childhood rhabdomyosarcoma incidence and survival in the United States, 1975-2005
- (2009) Simona Ognjanovic et al. CANCER
- Vincristine, Actinomycin, and Cyclophosphamide Compared With Vincristine, Actinomycin, and Cyclophosphamide Alternating With Vincristine, Topotecan, and Cyclophosphamide for Intermediate-Risk Rhabdomyosarcoma: Children's Oncology Group Study D9803
- (2009) Carola A.S. Arndt et al. JOURNAL OF CLINICAL ONCOLOGY
- Ipilimumab monotherapy in patients with pretreated advanced melanoma: a randomised, double-blind, multicentre, phase 2, dose-ranging study
- (2009) Jedd D Wolchok et al. LANCET ONCOLOGY
- Immunotherapy for Osteosarcoma: Genetic Modification of T cells Overcomes Low Levels of Tumor Antigen Expression
- (2009) Nabil Ahmed et al. MOLECULAR THERAPY
- A Pilot Study of Consolidative Immunotherapy in Patients with High-Risk Pediatric Sarcomas
- (2008) C. L. Mackall et al. CLINICAL CANCER RESEARCH
- Intensity-Modulated Radiotherapy With Use of Cone-Down Boost for Pediatric Head-and-Neck Rhabdomyosarcoma
- (2008) Mark W. McDonald et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Prognostic Factors in Metastatic Rhabdomyosarcomas: Results of a Pooled Analysis From United States and European Cooperative Groups
- (2008) Odile Oberlin et al. JOURNAL OF CLINICAL ONCOLOGY
- Treatment of children with metastatic soft tissue sarcoma with oral maintenance compared to high dose chemotherapy: Report of the HD CWS-96 trial
- (2008) Thomas Klingebiel et al. PEDIATRIC BLOOD & CANCER
- Comparison of results of a pilot study of alternating vincristine/doxorubicin/cyclophosphamide and etoposide/ifosfamide with IRS-IV in intermediate risk rhabdomyosarcoma: A report from the Children's Oncology Group
- (2006) Carola A.S. Arndt et al. PEDIATRIC BLOOD & CANCER
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now